NLRP3 and atherosclerosis: Consequently, NLRP3, which is involved in the pathogenesis of type 2 diabetes mellitus [44], atherosclerosis [45], cardiovascular [46], and neurodegenerative diseases [47], can be repressed by treatment with NIP3.